vs
福尼克斯（PLAB）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
福尼克斯的季度营收约是REPLIGEN CORP的1.1倍（$210.4M vs $197.9M），福尼克斯净利率更高（10.9% vs 6.7%，领先4.2%），REPLIGEN CORP同比增速更快（13.6% vs -5.5%），福尼克斯自由现金流更多（$25.2M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -3.8%）
福尼克斯是美国半导体光掩模制造商，2009年时位居全球第三大光掩模供应商，同时也是电子束产业倡议组织的成员，专注于为半导体行业提供关键的掩模产品，支撑芯片制造环节的图形转移需求。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
PLAB vs RGEN — 直观对比
营收规模更大
PLAB
是对方的1.1倍
$197.9M
营收增速更快
RGEN
高出19.1%
-5.5%
净利率更高
PLAB
高出4.2%
6.7%
自由现金流更多
PLAB
多$7.7M
$17.6M
两年增速更快
RGEN
近两年复合增速
-3.8%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $210.4M | $197.9M |
| 净利润 | $22.9M | $13.3M |
| 毛利率 | 33.7% | 52.5% |
| 营业利润率 | 22.9% | 9.0% |
| 净利率 | 10.9% | 6.7% |
| 营收同比 | -5.5% | 13.6% |
| 净利润同比 | -32.4% | 143.9% |
| 每股收益（稀释后） | $0.39 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLABRGEN
| Q4 25 | — | $197.9M | ||
| Q3 25 | $210.4M | $188.8M | ||
| Q2 25 | $211.0M | $182.4M | ||
| Q1 25 | $212.1M | $169.2M | ||
| Q4 24 | $222.6M | $174.1M | ||
| Q3 24 | $211.0M | $154.9M | ||
| Q2 24 | $217.0M | $154.1M | ||
| Q1 24 | $216.3M | $151.3M |
净利润PLABRGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $22.9M | $14.9M | ||
| Q2 25 | $8.9M | $14.9M | ||
| Q1 25 | $42.9M | $5.8M | ||
| Q4 24 | $33.9M | $-30.3M | ||
| Q3 24 | $34.4M | $-654.0K | ||
| Q2 24 | $36.3M | $3.3M | ||
| Q1 24 | $26.2M | $2.1M |
毛利率PLABRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | 33.7% | 53.2% | ||
| Q2 25 | 36.9% | 50.0% | ||
| Q1 25 | 35.6% | 53.6% | ||
| Q4 24 | 37.0% | 26.1% | ||
| Q3 24 | 35.6% | 50.0% | ||
| Q2 24 | 36.5% | 49.8% | ||
| Q1 24 | 36.6% | 49.5% |
营业利润率PLABRGEN
| Q4 25 | — | 9.0% | ||
| Q3 25 | 22.9% | 8.9% | ||
| Q2 25 | 26.4% | 7.6% | ||
| Q1 25 | 24.6% | 3.9% | ||
| Q4 24 | 25.1% | -17.7% | ||
| Q3 24 | 24.7% | -5.1% | ||
| Q2 24 | 25.8% | 1.0% | ||
| Q1 24 | 26.6% | 1.3% |
净利率PLABRGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | 10.9% | 7.9% | ||
| Q2 25 | 4.2% | 8.2% | ||
| Q1 25 | 20.2% | 3.4% | ||
| Q4 24 | 15.2% | -17.4% | ||
| Q3 24 | 16.3% | -0.4% | ||
| Q2 24 | 16.7% | 2.2% | ||
| Q1 24 | 12.1% | 1.4% |
每股收益（稀释后）PLABRGEN
| Q4 25 | — | $0.24 | ||
| Q3 25 | $0.39 | $0.26 | ||
| Q2 25 | $0.15 | $0.26 | ||
| Q1 25 | $0.68 | $0.10 | ||
| Q4 24 | $0.54 | $-0.55 | ||
| Q3 24 | $0.55 | $-0.01 | ||
| Q2 24 | $0.58 | $0.06 | ||
| Q1 24 | $0.42 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $575.8M | $767.6M |
| 总债务越低越好 | $16.0K | $542.2M |
| 股东权益账面价值 | $1.1B | $2.1B |
| 总资产 | $1.8B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.00× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资PLABRGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | $575.8M | $748.7M | ||
| Q2 25 | $558.4M | $708.9M | ||
| Q1 25 | $642.2M | $697.2M | ||
| Q4 24 | $640.7M | $757.4M | ||
| Q3 24 | $606.4M | $784.0M | ||
| Q2 24 | $559.9M | $809.1M | ||
| Q1 24 | $521.5M | $780.6M |
总债务PLABRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | $16.0K | $537.9M | ||
| Q2 25 | $19.0K | — | ||
| Q1 25 | $21.0K | — | ||
| Q4 24 | $25.0K | $525.6M | ||
| Q3 24 | $28.0K | — | ||
| Q2 24 | $2.5M | — | ||
| Q1 24 | $2.7M | — |
股东权益PLABRGEN
| Q4 25 | — | $2.1B | ||
| Q3 25 | $1.1B | $2.1B | ||
| Q2 25 | $1.1B | $2.1B | ||
| Q1 25 | $1.1B | $2.0B | ||
| Q4 24 | $1.1B | $2.0B | ||
| Q3 24 | $1.1B | $2.0B | ||
| Q2 24 | $1.0B | $2.0B | ||
| Q1 24 | $1.0B | $2.0B |
总资产PLABRGEN
| Q4 25 | — | $2.9B | ||
| Q3 25 | $1.8B | $2.9B | ||
| Q2 25 | $1.7B | $2.9B | ||
| Q1 25 | $1.7B | $2.9B | ||
| Q4 24 | $1.7B | $2.8B | ||
| Q3 24 | $1.6B | $2.8B | ||
| Q2 24 | $1.6B | $2.9B | ||
| Q1 24 | $1.6B | $2.8B |
负债/权益比PLABRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | 0.00× | 0.26× | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | 0.27× | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $50.1M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $25.2M | $17.6M |
| 自由现金流率自由现金流/营收 | 12.0% | 8.9% |
| 资本支出强度资本支出/营收 | 11.8% | 4.1% |
| 现金转化率经营现金流/净利润 | 2.19× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $64.5M | $93.9M |
8季度趋势，按日历期对齐
经营现金流PLABRGEN
| Q4 25 | — | $25.7M | ||
| Q3 25 | $50.1M | $48.1M | ||
| Q2 25 | $31.5M | $28.6M | ||
| Q1 25 | $78.5M | $15.0M | ||
| Q4 24 | $68.4M | $39.2M | ||
| Q3 24 | $75.1M | $49.3M | ||
| Q2 24 | $76.5M | $42.2M | ||
| Q1 24 | $41.5M | $44.7M |
自由现金流PLABRGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | $25.2M | $43.4M | ||
| Q2 25 | $-29.1M | $21.5M | ||
| Q1 25 | $43.3M | $11.4M | ||
| Q4 24 | $25.2M | $33.6M | ||
| Q3 24 | $50.7M | $42.3M | ||
| Q2 24 | $56.5M | $37.4M | ||
| Q1 24 | $-1.8M | $36.4M |
自由现金流率PLABRGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | 12.0% | 23.0% | ||
| Q2 25 | -13.8% | 11.8% | ||
| Q1 25 | 20.4% | 6.8% | ||
| Q4 24 | 11.3% | 19.3% | ||
| Q3 24 | 24.0% | 27.3% | ||
| Q2 24 | 26.0% | 24.3% | ||
| Q1 24 | -0.8% | 24.0% |
资本支出强度PLABRGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | 11.8% | 2.5% | ||
| Q2 25 | 28.7% | 3.9% | ||
| Q1 25 | 16.6% | 2.1% | ||
| Q4 24 | 19.4% | 3.2% | ||
| Q3 24 | 11.6% | 4.5% | ||
| Q2 24 | 9.2% | 3.1% | ||
| Q1 24 | 20.0% | 5.5% |
现金转化率PLABRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 2.19× | 3.23× | ||
| Q2 25 | 3.55× | 1.92× | ||
| Q1 25 | 1.83× | 2.57× | ||
| Q4 24 | 2.02× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.11× | 12.70× | ||
| Q1 24 | 1.59× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLAB
| High End Integrated Circuits | $53.6M | 25% |
| High End Flat Panel Displays | $53.5M | 25% |
| KR | $43.7M | 21% |
| Other | $42.1M | 20% |
| Mainstream Flat Panel Displays | $9.1M | 4% |
| Transferred At Point In Time | $8.4M | 4% |
RGEN
暂无分部数据
